Regen Biopharma Inc.Preferred / convertible
13F holders, Q3 2024 (September 30)1holders
$0.25avg. 13F price*
At the end of Q3 2024, 1 institutions reported holding Regen Biopharma Inc. in their 13F filings. The largest holder was Thompson Investment Management, Inc. ($2).
- Company
- Regen Biopharma Inc.
- CUSIP
- 75886M409
- Latest filing quarter
- Q3 2024
Total Exit/New Position Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $2 |
| Exits | 0 | $0 |
Ownership 1 holders
| Thompson Investment Management, Inc. | — | New | 8 | $2 |
"% of holder's portfolio" is REGEN BIOPHARMA INC's weight in each manager's 13F, not the share of Regen Biopharma Inc. the manager owns.